Recap: Biohaven Pharma Hldgs Q2 Earnings

Loading...
Loading...

Biohaven Pharma Hldgs BHVN reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Biohaven Pharma Hldgs missed estimated earnings by 48.06%, reporting an EPS of $-3.82 versus an estimate of $-2.58.

Revenue was up $122.15 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.91 which was followed by a 0.56% increase in the share price the next day.

Here's a look at Biohaven Pharma Hldgs's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -2.53 -2.04 -2.40 -2.74
EPS Actual -1.62 -2.32 -1.91 -2.62
Revenue Estimate 181.11M 173.69M 128.40M 78.13M
Revenue Actual 318.85M 190.01M 135.74M 92.93M

To track all earnings releases for Biohaven Pharma Hldgs visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...